摘要: In France, lung cancer is the principal cause of death by in men and fifth women. It causes 21,500 deaths per year corresponding to approximately 16% 23% male [16]. This mortality directly correlated with figures cigarette smoking [16, 24]. Less than 10% patients survive more 5 years, rate this being close its incidence [13, 16,
springer.com
sci-hub.st 参考文章(24)
NSB Rawson, , J Peto, An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. British Journal of Cancer. ,vol. 61, pp. 597- 604 ,(1990) , 10.1038/BJC.1990.133
M. H. Cullen, L. J. Billingham, C. M. Woodroffe, A. D. Chetiyawardana, N. H. Gower, R. Joshi, D. R. Ferry, R. M. Rudd, S. G. Spiro, J. E. Cook, C. Trask, E. Bessell, C. K. Connolly, J. Tobias, R. L. Souhami, Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life Journal of Clinical Oncology. ,vol. 17, pp. 3188- 3194 ,(1999) , 10.1200/JCO.1999.17.10.3188
M Paesmans, J P Sculier, P Libert, G Bureau, G Dabouis, J Thiriaux, J Michel, O Van Cutsem, R Sergysels, P Mommen, Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology. ,vol. 13, pp. 1221- 1230 ,(1995) , 10.1200/JCO.1995.13.5.1221
E Rapp, J L Pater, A Willan, Y Cormier, N Murray, W K Evans, D I Hodson, D A Clark, R Feld, A M Arnold, Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. Journal of Clinical Oncology. ,vol. 6, pp. 633- 641 ,(1988) , 10.1200/JCO.1988.6.4.633
Gary M. Strauss, PROGNOSTIC MARKERS IN RESECTABLE NON–SMALL CELL LUNG CANCER Hematology-oncology Clinics of North America. ,vol. 11, pp. 409- 434 ,(1997) , 10.1016/S0889-8588(05)70441-X
F. Levi, F. Lucchini, E. Negri, P. Boyle, C. La Vecchia, Cancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994 European Journal of Cancer. ,vol. 35, pp. 1477- 1516 ,(1999) , 10.1016/S0959-8049(99)00154-9
Robert E. Belliveau, Richard P. Spencer, Incidence and sites of bone lesions detected by99mTc-polyphosphate scans in patients with tumors Cancer. ,vol. 36, pp. 359- 363 ,(1975) , 10.1002/1097-0142(197508)36:2<359::AID-CNCR2820360210>3.0.CO;2-1
Bernward Passlick, Boris Kubuschok, Jakob R Izbicki, Olaf Thetter, Klaus Pantel, Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. The Annals of Thoracic Surgery. ,vol. 68, pp. 2053- 2058 ,(1999) , 10.1016/S0003-4975(99)01125-X
V. Hespanhol, H. Queiroga, A. Magalhães, A.R. Santos, M. Coelho, A. Marques, Survival predictors in advanced non-small cell lung cancer Lung Cancer. ,vol. 13, pp. 253- 267 ,(1995) , 10.1016/0169-5002(95)00497-1
Yvon Cormier, Dollard Bergeron, Jacques La Forge, Michel Lavandier, Marcien Fournier, Jacques Chenard, Marc Desmeules, Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma Cancer. ,vol. 50, pp. 845- 849 ,(1982) , 10.1002/1097-0142(19820901)50:5<845::AID-CNCR2820500507>3.0.CO;2-S